Just another pump and dump in the SP. MSB has lost all credibility when taking the steps needed for FDA approval. Just going to be another rejection and cash burn unfortunately.
- Forums
- ASX - By Stock
- MSB
- Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF, page-367
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B |
Open | High | Low | Value | Volume |
$1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23940 | $1.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 22571 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 23940 | 1.390 |
3 | 38984 | 1.385 |
4 | 46804 | 1.380 |
2 | 40933 | 1.375 |
3 | 25278 | 1.370 |
Price($) | Vol. | No. |
---|---|---|
1.395 | 22571 | 2 |
1.400 | 353114 | 5 |
1.405 | 39000 | 3 |
1.410 | 44610 | 7 |
1.415 | 77894 | 4 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online